Concepedia

Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck

Patrick Schöffski, G. Catimel, A.S.T. Planting, Droz Jp, Jaap Verweij, D. Schrijvers, L. Gras, A. H. G. J. Schrijvers, J. Wanders, A.-R. Hanauske

Annals of Oncology · 1999 · 104 citations · 11 references

DOIFull text

Open access

Concepts

References

11

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin

Michael S. Rooney, Julie A. Kish, Jeannie J. Kinzie et al. · Cancer · 1985 · 384 citations

, , +10

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 259 citations

, , +7

Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.

Julie A. Kish, Anibal Drelichman, Joseph B. Jacobs et al. · PubMed · 1982 · 237 citations

, , +14

Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

Arnon I. Dreyfuss, J. Clark, Charles M. Norris et al. · Journal of Clinical Oncology · 1996 · 233 citations

, , +12

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

Lloyd R. Kelland, G Abel · Cancer Chemotherapy and Pharmacology · 1992 · 138 citations

, , +12